TRIOBP
(TRIO and F-Actin Binding Protein (TRIOBP))
Protein Region
Middle Region
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-TRIOBP antibody (Catalog #: ARP39821_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
TRIOBP
(TRIO and F-Actin Binding Protein (TRIOBP))
Synonymes
tara Peptide, DFNB28 Peptide, TARA Peptide, dJ37E16.4 Peptide, AI428493 Peptide, EST478828 Peptide, Tara Peptide, mKIAA1662 Peptide, TRIO and F-actin binding protein Peptide, TRIO and F-actin-binding protein Peptide, TRIO and F-actin binding protein L homeolog Peptide, TRIO and F-actin binding protein-like Peptide, TRIOBP Peptide, LOC100354753 Peptide, triobp.L Peptide, TRIOBPL Peptide, Triobp Peptide
Sujet
TRIOBP is a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cel
Alias Symbols: DFNB28, FLJ39315, HRIHFB2122, KIAA1662, TARA, dJ37E16.4